FLGT Q2 2022 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q2 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$125M-18.4% YoY

Gross Profit

$65M52.1% margin

Operating Income

$13M10.2% margin

Net Income

$12M9.2% margin

EPS (Diluted)

$0.37

QoQ Revenue Growth

-60.9%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$8M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$151M

Stockholders' Equity

$1.3B

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$125M	$154M	-18.4%
Gross Profit	$65M	$118M	-44.6%
Operating Income	$13M	$99M	-87.1%
Net Income	$12M	$80M	-85.5%

Geographic Segments

UNITED STATES

$122M97%

Non-US

$3M3%